Tumor-associated macrophages (TAMs) expressing the multi-
ligand endocytic
receptor mannose receptor (CD206/MRC1) contribute to
tumor immunosuppression, angiogenesis,
metastasis, and relapse. Here, we describe a
peptide that selectively targets MRC1-expressing TAMs (
MEMs). We performed in vivo
peptide phage display screens in mice bearing 4T1 metastatic
breast tumors to identify
peptides that target peritoneal macrophages. Deep sequencing of the
peptide-encoding inserts in the selected phage pool revealed enrichment of the
peptide CSPGAKVRC (codenamed "UNO"). Intravenously injected FAM-labeled UNO (FAM-UNO) homed to
tumor and sentinel lymph node
MEMs in different
cancer models: 4T1 and MCF-7
breast carcinoma, B16F10
melanoma, WT-GBM
glioma and MKN45-P gastric
carcinoma. Fluorescence anisotropy assay showed that FAM-UNO interacts with recombinant CD206 when subjected to reducing conditions. Interestingly, the GSPGAK motif is present in all CD206-binding
collagens. FAM-UNO was able to transport drug-loaded nanoparticles into
MEMs, whereas particles without the
peptide were not taken up by MEMs. In ex vivo organ imaging, FAM-UNO showed significantly higher accumulation in sentinel lymph nodes than a control
peptide. This study suggests applications for UNO
peptide in diagnostic imaging and therapeutic targeting of
MEMs in solid
tumors.